Lymphatic Filariasis in Mainland Southeast Asia - MDPI

0 downloads 0 Views 4MB Size Report
2017, 2, 32; doi:10.3390/tropicalmed2030032 www.mdpi.com/journal/tropicalmed. Supplementary Materials: Lymphatic Filariasis in. Mainland Southeast Asia: A ...
Supplementary Materials: Lymphatic Filariasis in Mainland Southeast Asia: A Systematic Review and Meta-Analysis of Prevalence and Disease Burden Benjamin F. R. Dickson, Patricia M. Graves and William J. McBride Table S1. Quality Assessment of Included Peer-Reviewed Journal Articles. Study Author (publication year) [study year] [reference]

Sample Size

Hafiz et al. (2015) [2011] [33] Saha et al. (2011) [NSd] [55] Samad et al. (2013) [NS] [56]

+++ +++ ++

Leang et al. (2004) [2000–2001] [45] Priest et al. (2016) [2012] [52]

+++ +++

Dutta et al. (1995) [1992] [32] Khan et al. (1999) [NS] Study 1 [37] Khan et al. (1999) [NS] Study 2 [40] Khan et al. (1999) [NS] Study 3 [38] Khan et al. (2004) [NS] [39] Khan et al. (2015) [2012-2013] [41] Medhi et al. (2006) [2002–2003][47] Prakash et al. (1998) [1994] [51]

+++ ++ +++ ++ ++ ++ +++/+a +++

Ahmad et al. (2014) [NS] [25] Cox-Singh et al. (1999) [NS] [31] Hakim et al. (1995) [1992] [34] Jamail et al. (2005) [2001–2002] [35] Lim et al (2001) [NS] [46] Rahmah et al. (2003) [NS] [53] Rahmah et al. (2010) [?] [54]

+ + ++ +++ +++ +++ ++

Wan Omar et al. (2001) [NS]

Sampling Locatio Participants n Bangladesh Y Y ? Y ? ? Cambodia Y Y Y Y India ? Y Y Y Y Y ? ? Y Y ? ? Y Y Y Y Malaysia ? ? ? Y N Y N ? N ? Y Y N ?

Data Collection Adequate Infection Morbidity Assessment Assessment

Total Score

Y Y

Y Y -

10/10 7/8 5/8

Y Y

Y -

10/10 8/8

Y Y Y Y Y Y Y Y

Y ? ? Y Y Y Y

9/10 8/10 9/10 5/8 9/10 7/10 9/10 10/10

Y Y Y Y Y Y Y

-

4/8 5/8 5/8 5/8 5/8 8/8 4/8

++

?

Nb

Y

Y

6/10

++/+a

Thailand ?

?

Y

-

4.5/8

++

?

?

Y

-

5/8

+ +c +++

? N ?

? Y ?

Y Y N

Y Y -

6/10 6/10 4/8

++

?

Y

Y

?

7/10

+++ ++ +++

N ? Y

? Y Y

Y Y ?

-

5/8 6/10 7/8

++/+a

?

Nb

Y

Y

5.5/10

++/+a

?

?

Y

-

4.5/8

+ +++

? ?

? ?

Y Y

-

4/8 6/8

+++

?

?

Y

?

7/10

++

?

?

Y

-

5/8

[62] Bhumiratana et al. (2004) [2002] [28] Bhumiratana et al. (2005) [1998–2001] [26] Bhumiratana et al. (1999) [1998] [27] Bhumiratana et al (2002) [1999][29] Chansiri et al. (2002)[1997–2001][30] Jiraamonnimit et al. (2009) [2005–2006] [36] Koyadun et al. (2003) [2001–2002] [43] Koyadun et al. (2005) [2003] [42] Krairittichai et al. (2012) [2010] [44] Nuchprayoon et al. (2003) [NS] Study 1 [48] Nuchprayoon et al. (2003) [NS] Study 2 [49] Nuchprayoon et al. (2001) [NS] [50] Satimai et al. (2011) [NS] [57] Swaddiwudhipong et al.(1996) [1995] [58] Triteeraprapab et al. (1999) [NS][61]

Trop. Med. Infect. Dis. 2017, 2, 32; doi:10.3390/tropicalmed2030032

www.mdpi.com/journal/tropicalmed

Trop. Med. Infect. Dis. 2017, 2, 32

S2 of S14

Triteeraprapab et al. (2001) [NS] Study 1 [59] Triteeraprapab et al. (2001) [1999] Study 2 [60]

+++

?

?

Y

-

6/8

++

N

Y

Y

-

5/8

Y= Sampling/Assessment adequate (2 points). ? = Not clear/not stated (1 point). N= Sampling/Assessment not adequate (0 points). +++ = good (>1000) (2 points), ++ = adequate (300-1000) (1 point), + = poor (